American Heart Association consortium advances development of evidence-based health tech solutions
SANTA CLARA, Calif., May 29, 2025 /PRNewswire/ – Zeto, Inc., a fast-growing medical technology company revolutionizing EEG diagnostics with its cutting-edge devices and advanced cloud platform, has joined the American Heart Association Center for Health Technology & Innovation’s (the Center) Innovators’ Network. The Center is focused on building and fostering health technology relationships to develop innovative and scalable solutions.
The Innovators’ Network is a consortium connecting entrepreneurs, providers, researchers and payers to advance cardiovascular and brain health innovation. Innovators’ Network members also have the opportunity to access the Association’s digital evidence-based scientific guidelines and clinical recommendations as they develop digital healthcare technologies. Members interact with the Center in different ways, including building models for clinical outcome studies, which lowers the significant cost of developing those studies independently, helping connect the science to technology and providing evidence that a digital platform improves healthcare outcomes – a key concern for providers and payers.
“The Center aims to advance the rapid, efficient and effective development of healthcare technology,” said Robert A. Harrington, M.D., FAHA, said Robert A. Harrington, M.D., FAHA, volunteer past president of the American Heart Association (2019-2020), chair of the American Heart Association’s Health Tech Advisory Group for the Center and the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine and provost for medical affairs of Cornell University. “Joining the Innovators’ Network gives members the opportunity to leverage the consortium and work toward broadening and deepening their engagement in this arena.”
“We’re happy to join the American Heart Association’s Innovators’ Network to advance scalable, evidence-based solutions in neurology,” said Aswin Gunasekar, Founder and CEO of Zeto, Inc. “At Zeto, we strive to bridge clinical needs with technology that’s both accessible and impactful. We’re excited to join the Center to drive meaningful innovation in brain monitoring and improve outcomes in critical care and beyond.”
Non-convulsive status epilepticus (prolonged seizures) is a major neuro-emergency in acute care, with up to 1 in 3 neurological ICU patients at risk for seizures that can lead to brain injury or death. To help address this challenge, Zeto offers rapid, full-montage EEG with AI-powered status epilepticus and seizure detection — enabling timely, bedside diagnosis and intervention when it matters most.
1 Seizure Management in the Intensive Care Unit – PMC
About Zeto, Inc.
Zeto, Inc., an award-winning medical technology company, is at the forefront of advancing EEG brain monitoring and diagnostics in healthcare. Through its innovative wearable devices, Zeto makes brain monitoring accessible in diverse clinical settings, including the ICU, ED, hospitals, offices, and at home. Backed by a powerful cloud-based platform, Zeto delivers nationwide monitoring and interpretation services by neurologists, along with AI-powered notifications for conditions such as seizures and epilepsy. Looking ahead, Zeto plans to expand its capabilities to detect and manage conditions like stroke and traumatic brain injury. Zeto’s EEG systems, which received FDA clearances in 2018 and 2024, are currently commercially available in the United States.
To learn more about Zeto’s products, please visit: https://zeto-inc.com or email us at info@zetoinc.com.
Source: Newswise